Abstract
10.1055/a-2228-6118 In the above-mentioned article the COI has been updated. The correct COI is: FML is a shareholder of curantis UG (Ltd.) and received a research grant from Endosane Pharmaceuticals GmbH. Furthermore, FML is the co-founder and Medical Director of Endosane Pharmaceuticals GmbH, although this role operates through a consultancy agreement with curantis UG (Ltd.) as the primary affiliation. CR is a shareholder of lero bioscience UG (Ltd). CR and ID are currently employed by Endosane Pharmaceuticals GmbH. This was corrected in the online version on 09.02.2026. Article published online: 13 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany